Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- DIAGNOSIS NEWS IN BRIEF
February 12, 2001
- Aiming to Rank 20th within This Year: Mr Payne of Pharmacia
February 12, 2001
- Takeda to Carry Out Reform with Global Standard: President Takeda
February 5, 2001
- 50% of Outpatients Should Pay Fixed Rate Copayment Overall: HIB
February 5, 2001
- WORLD NEWS IN BRIEF
February 5, 2001
- Korosho Holds 1st Explanatory Meeting for Prefectural Governmental Officials -2-
February 5, 2001
- JPA Holds National Convention to Prevent Dispensing Errors
February 5, 2001
- DIAGNOSTIC NEWS IN BRIEF
February 5, 2001
- BUSINESS NEWS IN BRIEF
February 5, 2001
- Cost Curtailment Policy Should Now Target Hospitalization: JHEF Seminar
February 5, 2001
- Takara Obtains Marketing Rights for Analysis Services from GeneFormatics
February 5, 2001
- ON THE MOVE
February 5, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 5, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
February 5, 2001
- Kirin Obtains Rights to Cerus's Allogeneic Cellular Immune Therapy Technology
February 5, 2001
- NHI Prices of 12 New Ingredients Including Tamiflu, Relenza Approved
February 5, 2001
- Kissei, Teikoku Hormone to Codevelop Threatened Premature Delivery Treatment
February 5, 2001
- Peak Sales of 5 New Drugs Expected to Exceed \10 Bil.: Chuikyo
February 5, 2001
- Proposed Human Genome Research GL Explained by Kyoto Univ. Professor
February 5, 2001
- Chuikyo Members Point Out Problems with NHI Price Setting Rules
February 5, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…